178 related articles for article (PubMed ID: 15041573)
1. The effect of erythropoietin on allogeneic blood requirement in patients undergoing elective liver resection: a model simulation.
Lentschener C; Gomola A; Grabar S; Soubrane O; Dousset B; Massault PP; Penhoud C; Ozier Y
Anesth Analg; 2004 Apr; 98(4):921-926. PubMed ID: 15041573
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery.
Tamir L; Fradin Z; Fridlander M; Ashkenazi U; Zeidman A; Cohen AM; Hendel D; Mittelman M
Haematologia (Budap); 2000; 30(3):193-201. PubMed ID: 11128112
[TBL] [Abstract][Full Text] [Related]
5. [Case-control study on the efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in elderly patients undergoing elective surgery for femoral intertrochanteric fractures].
Xie B; Tian J; Yang C; Zhou DP; Xiang LB
Zhongguo Gu Shang; 2015 Jul; 28(7):633-7. PubMed ID: 26399106
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
8. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
MacLaren R; Sullivan PW
Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
[TBL] [Abstract][Full Text] [Related]
11. Preoperative erythropoietin in spine surgery.
Colomina MJ; Bagó J; Pellisé F; Godet C; Villanueva C
Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S40-9. PubMed ID: 15197631
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac surgery without homologous blood transfusion--the effectiveness and the indication of recombinant human erythropoietin].
Watanabe Y; Fuse K; Naruse Y; Kobayashi T; Yamamoto S; Konishi H; Horii T
Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):499-507. PubMed ID: 8035068
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
García-Erce JA; Cuenca J; Haman-Alcober S; Martínez AA; Herrera A; Muñoz M
Vox Sang; 2009 Oct; 97(3):260-7. PubMed ID: 19497085
[TBL] [Abstract][Full Text] [Related]
14. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
House AA; Pham B; Pagé DE
Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
[TBL] [Abstract][Full Text] [Related]
15. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
[TBL] [Abstract][Full Text] [Related]
16. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement.
Gombotz H; Gries M; Sipurzynski S; Fruhwald S; Rehak P
Acta Anaesthesiol Scand; 2000 Jul; 44(6):737-42. PubMed ID: 10903019
[TBL] [Abstract][Full Text] [Related]
17. Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
Mirtsching B; Charu V; Vadhan-Raj S; Colowick AB; Rossi G; Tomita D; McGuire WP
Oncology (Williston Park); 2002 Oct; 16(10 Suppl 11):31-6. PubMed ID: 12435171
[TBL] [Abstract][Full Text] [Related]
18. Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation.
Ellermann I; Bueckmann A; Eveslage M; Buddendick H; Latal T; Niehoff D; Geissler RG; Hempel G; Kerkhoff A; Berdel WE; Roeder N; Van Aken HK; Zarbock A; Steinbicker AU
Anesth Analg; 2018 Nov; 127(5):1202-1210. PubMed ID: 29944518
[TBL] [Abstract][Full Text] [Related]
19. rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study.
Hunault-Berger M; Tanguy-Schmidt A; Rachieru P; Lévy V; Truchan-Graczyk M; Francois S; Gardembas-Pain M; Dib M; Foussard C; Piard N; Godon A; Solal-Celigny P; Ifrah N
Bone Marrow Transplant; 2005 May; 35(9):903-7. PubMed ID: 15765111
[TBL] [Abstract][Full Text] [Related]
20. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
Baron JF
Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
